Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)
伊克珠单抗与低剂量IL-2、秋水仙碱与标准疗法治疗中重度COVID-19住院患者的疗效和安全性比较:一项试点随机临床试验(STRUCK:使用细胞因子抑制剂的生存试验)
期刊:Revista Da Sociedade Brasileira De Medicina Tropical
影响因子:2.3
doi:10.1590/0037-8682-0565-2022
Bonifácio, Lívia Pimenta; Ramacciotti, Eduardo; Agati, Leandro Barile; Vilar, Fernando Crivelenti; Silva, Anna Christina Tojal da; Louzada Júnior, Paulo; Fonseca, Benedito Antônio Lopes da; Souza, Hayala Cristina Cavenague de; Oliveira, Caroline Candida Carvalho de; Aguiar, Valéria Cristina Resende; Quadros, Carlos Augusto de Aguiar; Dusilek, Cesar; Itinose, Kengi; Risson, Ricardo; Ferreira, Lucas Roberto Rivabem; Lopes, Renato Delascio; Kallas, Esper Georges; Bellissimo-Rodrigues, Fernando